Swiss scientists use smartphones and AI to track MS
NCT ID NCT06526364
Summary
This study aims to better understand how multiple sclerosis (MS) starts and progresses by collecting detailed health data from about 100 patients in Switzerland. Participants will use a smartphone app to track symptoms and complete regular tests, while researchers analyze this information alongside medical scans and blood samples. The goal is to find digital and biological markers that can help doctors monitor the disease more continuously and make better treatment decisions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB)
RECRUITINGBasel, 4031, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.